• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身凝血酶原II - A抗凝剂的一些特性。

Some properties of autoprothrombin II-A anticoagulant.

作者信息

Emekli N B, Ulutin O N

出版信息

Bibl Haematol. 1977;44:15-20. doi: 10.1159/000402146.

DOI:10.1159/000402146
PMID:617778
Abstract

Autoprothrombin II-A anticoagulant was isolated from bovine prothrombin. Purified prothrombin was applied to DEAE-cellulose chromatography after incubation with thrombin. Four protein peaks were obtained where the third peak corresponded to the anti-coagulant effect. The fractions under the third peak were pooled together and the anticoagulant effect was evaluated with different methods. From 25,470 +/- 2,800 U of prothrombin, 5,800 +/- 1,400 U of inhibitor were obtained. The inhibitor was found to be most effective at pH 7.2--7.8. In vitro, the inhibitor inhibited the thrombin time and the plasma clotting time highly significantly but had no effect on euglobulin lysis time and fibrin plates. In vivo, when injected into rabbits, the inhibitor effect was also significant on the same tests. The autoprothombin II-A anticoagulant had a protective effect on DIC formation with rabbit brain thromboplastin administration. This protective effect was found to be statistically significant.

摘要

自凝血酶原II-A抗凝剂是从牛凝血酶原中分离出来的。纯化后的凝血酶原在与凝血酶孵育后应用于DEAE-纤维素色谱法。得到了四个蛋白峰,其中第三个峰对应抗凝作用。合并第三个峰下的组分,并用不同方法评估其抗凝效果。从25,470±2,800单位的凝血酶原中获得了5,800±1,400单位的抑制剂。发现该抑制剂在pH 7.2-7.8时最有效。在体外,该抑制剂显著抑制凝血酶时间和血浆凝固时间,但对优球蛋白溶解时间和纤维蛋白平板无影响。在体内,当注入兔子体内时,在相同试验中该抑制剂的作用也很显著。自凝血酶原II-A抗凝剂对给予兔脑凝血活酶诱导的弥散性血管内凝血(DIC)形成具有保护作用。发现这种保护作用具有统计学意义。

相似文献

1
Some properties of autoprothrombin II-A anticoagulant.自身凝血酶原II - A抗凝剂的一些特性。
Bibl Haematol. 1977;44:15-20. doi: 10.1159/000402146.
2
Improved procedures for the purification of selected vitamin K-dependent proteins.用于纯化特定维生素K依赖性蛋白质的改进程序。
Prep Biochem. 1976;6(5):307-38. doi: 10.1080/00327487608061622.
3
Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.通过选择性抑制单个促凝血维生素K依赖性凝血因子来评估华法林在兔体内的抗凝作用机制。
J Clin Invest. 1993 Nov;92(5):2131-40. doi: 10.1172/JCI116814.
4
A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.一种高亲和力、解毒剂可控的凝血酶原和凝血酶结合 RNA 适体可抑制凝血酶生成和凝血酶活性。
J Thromb Haemost. 2012 May;10(5):870-80. doi: 10.1111/j.1538-7836.2012.04679.x.
5
HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.HD1 是一种凝血酶和凝血酶原结合的 DNA 适体,通过减弱凝血酶原激活和凝血酶反馈反应来抑制凝血酶生成。
Thromb Haemost. 2010 Jan;103(1):83-93. doi: 10.1160/TH09-04-0237. Epub 2009 Sep 15.
6
Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom.竹叶青蛇毒抗凝成分的纯化及性质
Biochim Biophys Acta. 1975 Apr 29;386(2):479-92. doi: 10.1016/0005-2795(75)90291-3.
7
Anticoagulant Activities of Indobufen, an Antiplatelet Drug.吲哚布芬的抗凝血活性,一种抗血小板药物。
Molecules. 2018 Jun 15;23(6):1452. doi: 10.3390/molecules23061452.
8
The protective effect of autoprothrombin II - anticoagulant on experimental DIC in animals.自身凝血酶原II - 抗凝剂对动物实验性弥散性血管内凝血的保护作用。
Haematologica. 1980 Oct;65(5):644-51.
9
Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources.使用来自牛、人及兔源的组织因子,在凝血酶原时间试验中比较正常凝血因子IX与凝血因子IX Bm变体希洛的行为。
Am J Hematol. 1993 Jul;43(3):177-82. doi: 10.1002/ajh.2830430304.
10
The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.通过等电聚焦法分离凝血因子II(凝血酶原)和IX(血浆凝血活酶成分)。
Biochim Biophys Acta. 1970 Mar 31;200(3):475-85.